256 related articles for article (PubMed ID: 30187047)
1. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of gold(I) phosphine complexes containing the 2-BrC
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies.
González-Barcia LM; Fernández-Fariña S; Rodríguez-Silva L; Bermejo MR; González-Noya AM; Pedrido R
J Inorg Biochem; 2020 Feb; 203():110931. PubMed ID: 31786438
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer gold(I) phosphine complexes: Cyclic trimers and tetramers containing the P-Au-P moiety.
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
J Inorg Biochem; 2017 Oct; 175():1-8. PubMed ID: 28686996
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Gold(I) Complexes Containing Cinnamide: In Vitro Evaluation of Anticancer Activity in 2D and 3D Spheroidal Models of Melanoma and In Vivo Angiogenesis.
Ganga Reddy V; Srinivasa Reddy T; Privér SH; Bai Y; Mishra S; Wlodkowic D; Mirzadeh N; Bhargava S
Inorg Chem; 2019 May; 58(9):5988-5999. PubMed ID: 30985125
[TBL] [Abstract][Full Text] [Related]
6. Potent and Selective Cytotoxic and Anti-inflammatory Gold(III) Compounds Containing Cyclometalated Phosphine Sulfide Ligands.
Reddy TS; Pooja D; Privér SH; Luwor RB; Mirzadeh N; Ramesan S; Ramakrishna S; Karri S; Kuncha M; Bhargava SK
Chemistry; 2019 Nov; 25(62):14089-14100. PubMed ID: 31414501
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
8. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
9. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
[TBL] [Abstract][Full Text] [Related]
10. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, properties, and antitumor effects of a new mixed phosphine gold(I) compound in human colon cancer cells.
Lupidi G; Avenali L; Bramucci M; Quassinti L; Pettinari R; Khalife HK; Gali-Muhtasib H; Marchetti F; Pettinari C
J Inorg Biochem; 2013 Jul; 124():78-87. PubMed ID: 23632460
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets.
Shaik N; Martínez A; Augustin I; Giovinazzo H; Varela-Ramírez A; Sanaú M; Aguilera RJ; Contel M
Inorg Chem; 2009 Feb; 48(4):1577-87. PubMed ID: 19146434
[TBL] [Abstract][Full Text] [Related]
13. Imidazole-based phosphane gold(I) complexes as potential agents for cancer treatment: synthesis, structural studies and antitumour activity.
Kunz PC; Kassack MU; Hamacher A; Spingler B
Dalton Trans; 2009 Oct; (37):7741-7. PubMed ID: 19759948
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
15. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
Arcau J; Andermark V; Aguiló E; Gandioso A; Moro A; Cetina M; Lima JC; Rissanen K; Ott I; Rodríguez L
Dalton Trans; 2014 Mar; 43(11):4426-36. PubMed ID: 24302256
[TBL] [Abstract][Full Text] [Related]
16. Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.
Rubbiani R; Zehnder TN; Mari C; Blacque O; Venkatesan K; Gasser G
ChemMedChem; 2014 Dec; 9(12):2781-90. PubMed ID: 25377650
[TBL] [Abstract][Full Text] [Related]
17. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
18. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
19. Heteronuclear gold(I)-silver(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines.
Barreiro E; Casas JS; Couce MD; Sánchez A; Sordo J; Vázquez-López EM
J Inorg Biochem; 2014 Feb; 131():68-75. PubMed ID: 24269769
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and Antiangiogenic Properties of Gold(III) Complexes Containing Cycloaurated Triphenylphosphine Sulfide Ligands.
Srinivasa Reddy T; Privér SH; Mirzadeh N; Luwor RB; Ganga Reddy V; Ramesan S; Bhargava SK
Inorg Chem; 2020 Apr; 59(8):5662-5673. PubMed ID: 32255617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
